Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04263909 · ClinicalTrials.gov registry record · Phase 4
The Impact of Sublingual Sufentanil on Postoperative Pain and Analgesic Requirements in Spine Surgery Patients
A Phase 4 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 199
- Enrollment target
NCT04263909 is a Phase 4 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 199 participants.
The verdict
NCT04263909, a Phase 4 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 199 participants
- Enrollment target
Study Summary
In this study the investigators plan to examine the perioperative use of sufentanil sublingual (SL) in the analgesic regimen for spine surgery, one of the most common surgeries performed in the US. Patients undergoing spinal fusion surgery often experience severe pain during the first three postoperative days. Currently, no data are available for this patient population which routinely experiences moderate to severe acute pain. The investigators will analyze whether sufentanil SL is associated with lower opioid consumption in the post anesthesia care unit and pain scores.
Interventions
- DRUG Sublingual Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2023-12-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04263909
The ClinicalTrials.gov registry entry for NCT04263909 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 199 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sublingual Tablet is the first listed.
NCT04263909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04263909 about?
NCT04263909 is a clinical study titled "The Impact of Sublingual Sufentanil on Postoperative Pain and Analgesic Requirements in Spine Surgery Patients". In this study the investigators plan to examine the perioperative use of sufentanil sublingual (SL) in the analgesic regimen for spine surgery, one of the most common surgeries performed in the US. Patients undergoing spinal fusion surgery often experience severe pain during the first three postoper...
What is the current status of trial NCT04263909?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 199 participants. The study started on 2020-12-01. Estimated completion is 2023-12-30.
What interventions are being tested in trial NCT04263909?
The interventions under investigation include: Sublingual Tablet (DRUG).
Who is sponsoring clinical trial NCT04263909?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.